Mölndal, Sweden

Per-Göran Gillberg

USPTO Granted Patents = 52 

 

Average Co-Inventor Count = 3.5

ph-index = 16

Forward Citations = 607(Granted Patents)

Forward Citations (Not Self Cited) = 57(Oct 12, 2025)


Location History:

  • Molndal, SE (2009 - 2022)
  • Asbro, SE (2022)
  • Mölndal, SE (2017 - 2023)
  • Åsbro, SE (2021 - 2024)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
52 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Per-Göran Gillberg in Pharmaceutical Science

Introduction

Per-Göran Gillberg is a distinguished inventor based in Mölndal, Sweden, with an impressive portfolio of 49 patents. His work primarily focuses on the development of novel compounds that serve medical purposes, especially in the fields of liver and gastrointestinal diseases. His contributions to pharmaceutical science have paved the way for advancements in treatments for various metabolic disorders.

Latest Patents

One of Gillberg's notable patents includes the invention of Benzothia(di)azepine compounds and their use as bile acid modulators. This invention revolves around the derivative compounds of 1,5-benzothiazepine and 1,2,5-benzothiadiazepine, which exhibit the ability to inhibit the apical sodium-dependent bile acid transporter (ASBT) and/or liver bile acid transport (LBAT). These compounds play a vital role in developing pharmaceutical compositions aimed at treating cardiovascular diseases, disorders related to fatty acid metabolism, glucose utilization, gastrointestinal issues, and various liver diseases.

Another significant patent involves specific IBAT inhibitors designed for the prophylaxis and treatment of liver diseases. This invention not only details the inhibitors but also encompasses compositions that utilize these compounds, methods for treating affected disorders, and kits that include the therapeutic substances.

Career Highlights

Per-Göran Gillberg has worked with prestigious companies like Albireo AB, where he contributed to innovative projects targeting bile acid modulation and liver health. His expertise in the field has helped shape research and development within the pharmaceutical industry, highlighting his ability to translate complex scientific concepts into practical therapeutics.

Collaborations

Throughout his career, Gillberg has collaborated with notable colleagues such as Ingemar Starke and Santosh Shripad Kulkarni. These partnerships reflect a commitment to fostering innovation and advancing medical research through teamwork and shared expertise.

Conclusion

In summary, Per-Göran Gillberg's 49 patents underscore his significant impact on pharmaceutical innovation, particularly in liver and gastrointestinal health. Through his latest inventions, he continues to influence the treatment landscape for various metabolic disorders, demonstrating the critical role of inventors in modern medicine. His collaborative efforts and career achievements speak to an enduring legacy of innovation in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…